Literature DB >> 8244811

Vaginal stenosis and sexual function following intracavitary radiation for the treatment of cervical and endometrial carcinoma.

D W Bruner1, R Lanciano, M Keegan, B Corn, E Martin, G E Hanks.   

Abstract

PURPOSE: This study was designed to document the incidence and degree of vaginal stenosis, sexual activity, and satisfaction in women treated with intracavitary radiation therapy for cervical or endometrial carcinoma. METHODS AND MATERIALS: The incidence of vaginal stenosis in 90 patients treated for either cervical carcinoma (n = 42) or endometrial carcinoma (n = 48) with standard doses of intracavitary radiation from 1989 to 1992 with at least 6 months follow-up was recorded. Vaginal length was measured using a modified vaginal dilator calibrated in centimeters. Semistructured patient interviews documented pretreatment and posttreatment sexual activity and sexual satisfaction.
RESULTS: Vaginal length was found to be dependent on diagnosis (cervical vs. endometrial), stage (I vs. II/III), and follow-up interval (6-12 months, 12-24 months, and > 24 months). Slightly more women reported sexual activity post vs. pretreatment (31% active pretreatment vs. 43% active posttreatment). However, 22% of women reported a decrease in sexual frequency and 37% reported a decrease in sexual satisfaction. Reports for all parameters were worse for women treated for cervical carcinoma vs. women treated for endometrial carcinoma with the exception of dyspareunia.
CONCLUSION: High-dose radiation for either cervical or endometrial carcinoma at standard doses with or without hysterectomy can cause a decrease in vaginal length as compared to the normal vaginal length of 8 to 9 cm documented by Masters and Johnson. Women treated with intracavitary implants remained as sexually active postimplant as preimplant, however, coital frequency and sexual satisfaction decreased while dyspareunia increased. The decrease in vaginal length may explain in part the decrease in sexual satisfaction but cause and effect have not been established.

Entities:  

Mesh:

Year:  1993        PMID: 8244811     DOI: 10.1016/0360-3016(93)90455-5

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  33 in total

1.  Chore or priority? Barriers and facilitators affecting dilator use after pelvic radiotherapy for gynaecological cancer.

Authors:  Carissa Bonner; Kathryn Nattress; Caroline Anderson; Jonathan Carter; Chris Milross; Shannon Philp; Ilona Juraskova
Journal:  Support Care Cancer       Date:  2011-12-08       Impact factor: 3.603

2.  Dosimetric Predictors of Radiation-Induced Vaginal Stenosis After Pelvic Radiation Therapy for Rectal and Anal Cancer.

Authors:  Christina H Son; Ethel Law; Jung Hun Oh; Aditya P Apte; T Jonathan Yang; Elyn Riedel; Abraham J Wu; Joseph O Deasy; Karyn A Goodman
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-04-28       Impact factor: 7.038

Review 3.  The microbiome and gynaecological cancer development, prevention and therapy.

Authors:  Paweł Łaniewski; Zehra Esra Ilhan; Melissa M Herbst-Kralovetz
Journal:  Nat Rev Urol       Date:  2020-02-18       Impact factor: 14.432

4.  Toward clinical care guidelines for supporting rehabilitative vaginal dilator use with women recovering from cervical cancer.

Authors:  Kimberley Cullen; Karen Fergus; Tracey DasGupta; Iwa Kong; Marg Fitch; Catherine Doyle; Lauran Adams
Journal:  Support Care Cancer       Date:  2013-02-17       Impact factor: 3.603

Review 5.  Vaginal dilator therapy for women receiving pelvic radiotherapy.

Authors:  Tracie Miles; Nick Johnson
Journal:  Cochrane Database Syst Rev       Date:  2014-09-08

Review 6.  Contemporary quality of life issues affecting gynecologic cancer survivors.

Authors:  Jeanne Carter; Richard Penson; Richard Barakat; Lari Wenzel
Journal:  Hematol Oncol Clin North Am       Date:  2011-12-16       Impact factor: 3.722

7.  Radiation-induced morphological changes in the vagina.

Authors:  K Kirchheiner; E Fidarova; R A Nout; M P Schmid; A Sturdza; E Wiebe; A Kranz; S Polterauer; R Pötter; W Dörr
Journal:  Strahlenther Onkol       Date:  2012-09-29       Impact factor: 3.621

8.  Noninvasive evaluation of vaginal fibrosis following radiotherapy for gynecologic malignancies: a feasibility study with ultrasound B-mode and Nakagami parameter imaging.

Authors:  Xiaofeng Yang; Peter Rossi; Deborah Watkins Bruner; Srini Tridandapani; Joseph Shelton; Tian Liu
Journal:  Med Phys       Date:  2013-02       Impact factor: 4.071

9.  Holding back sharing concerns, dispositional emotional expressivity, perceived unsupportive responses and distress among women newly diagnosed with gynecological cancers.

Authors:  Sharon Manne; Shannon Myers; Melissa Ozga; David Kissane; Debby Kashy; Stephen Rubin; Carolyn Heckman; Norm Rosenblum
Journal:  Gen Hosp Psychiatry       Date:  2013-10-09       Impact factor: 3.238

10.  Dilator Use After Vaginal Brachytherapy for Endometrial Cancer: A Randomized Feasibility and Adherence Study.

Authors:  Alexandra Hanlon; William Small; Jonathan Strauss; Lilie L Lin; Laura Hanisch; Liming Huang; Jinbing Bai; Jessica Wells; Deborah Watkins Bruner
Journal:  Cancer Nurs       Date:  2018 May/Jun       Impact factor: 2.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.